Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Depreciation and Depletion (2023 - 2025)

Historic Depreciation and Depletion for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $1.3 million.

  • Metagenomi's Depreciation and Depletion fell 293.26% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 643.09%. This contributed to the annual value of $5.4 million for FY2024, which is 2852.39% up from last year.
  • According to the latest figures from Q3 2025, Metagenomi's Depreciation and Depletion is $1.3 million, which was down 293.26% from $1.3 million recorded in Q2 2025.
  • Metagenomi's 5-year Depreciation and Depletion high stood at $1.5 million for Q4 2024, and its period low was $841000.0 during Q1 2023.
  • In the last 3 years, Metagenomi's Depreciation and Depletion had a median value of $1.3 million in 2024 and averaged $1.2 million.
  • As far as peak fluctuations go, Metagenomi's Depreciation and Depletion skyrocketed by 5136.74% in 2024, and later tumbled by 293.26% in 2025.
  • Metagenomi's Depreciation and Depletion (Quarter) stood at $1.2 million in 2023, then increased by 21.65% to $1.5 million in 2024, then decreased by 9.38% to $1.3 million in 2025.
  • Its Depreciation and Depletion stands at $1.3 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.4 million for Q1 2025.